The designation recognises the vaccine\u2019s potential to address the unmet medical need arising from the devastating Nipah virus disease, which can be fatal in up to 85% of cases.
As part of the Hashemite Kingdom of Jordan\u2019s 79th Independence Day celebrations on 25 May, His Majesty King Abdullah II bestowed the King Abdullah II Ibn Al Hussein Order for Distinction upon Omar El Muhanna, Senior Operations and Strategy Executive at NDM\u2019s Clinical BioManufacturing Facility.
Meet the global experts set to present on the latest scientific advancements that will predict, identify and control future epidemic and pandemic threats.
The International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) has been awarded up to \u00a316.5 million to build on its globally-recognised efforts to prevent illness and deaths from epidemic-prone infectious diseases.
Co-led by PSI Director Professor Sir Peter Horby, the RECOVERY trial was defined \"one of the most well-known studies supported by the NIHR with clear national and global impact\u201d.
This week, University of Oxford researchers published the first paper mapping clinical ethics questions raised by new metagenomic techniques for diagnosing disease in clinical practice.
The deadline for abstract submissions and bursary applications for the International Pandemic Sciences Conference 2025\u202f has been extended to 23:59 GMT on Wednesday 26 February.
In the first study of this kind, PSI and Oxford researchers partner with global colleagues to outline how Artificial Intelligence can transform infectious disease research and save more lives.
PSI and Institut Pasteur de Dakar (IPD) will cooperate on developing vaccines and rapid diagnostics \u2013 as well as strengthening workforce in the vaccinology, clinical trials and biomanufacturing sectors.
A study in pigs, which shows that inhaled vaccines could potentially reduce viral transmission and improve efficiency, is an important step toward advancing vaccines for human use.
Representatives from academia, industry, civil society, and the public sector are invited to register for the International Pandemic Sciences Conference 2025, taking place in Oxford and online from 30 June to 1 July 2025.
Oxford Cancer, the Oxford Vaccine Group and the Pandemic Sciences Institute have announced a new collaboration with Belgian biotech innovator Univercells.
University of Oxford collaborators from the Pandemic Sciences Institute and the Department of Statistics will keep contributing actively to the new iteration of the Health Protection Research Unit in Emerging and Zoonotic Infections.
![\"\"](\"https://www.cbf.ox.ac.uk/news/oxford-vaccine-against-deadly-nipah-virus-granted-european-medicines-agency-prime-designation/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n